Second-line chemotherapy in elderly patients with advanced pancreatic cancer: A mono-institutional retrospective experience

被引：0
|
作者：
Trovato, Giovanni
Bensi, Maria
Beccia, Viria
Spring, Alexia
Barone, Diletta
Ceccarelli, Anna
Perazzo, Serena
Messina, Gloria
Chiofalo, Laura
Bagala, Cinzia
Quero, Giuseppe
Alfieri, Sergio
Tortora, Giampaolo
Salvatore, Lisa
机构：
[1] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Comprehens Canc Ctr, Oncol Med, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Comprehens Canc Ctr, Chirurg Digest, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
130-273-572; 130-540-543-12277-2683; 130-3426-5390-2622-5397; 261-566-148; 613-135-244-3829; 613-135-2370-7650-2700; 283-2494; 8; 6; 5; 3; 176; 92; 1692; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.606
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：606 / 606
页数：1
相关论文
共 50 条
  • [21] Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis
    Zheng Wang
    Zhi-Gang Ren
    Ning-Yi Ma
    Jian-Dong Zhao
    Zhen Zhang
    Xue-Jun Ma
    Jiang Long
    Jin Xu
    Guo-Liang Jiang
    Radiation Oncology, 10
  • [22] Intensity modulated radiotherapy for locally advanced and metastatic pancreatic cancer: a mono-institutional retrospective analysis
    Wang, Zheng
    Ren, Zhi-Gang
    Ma, Ning-Yi
    Zhao, Jian-Dong
    Zhang, Zhen
    Ma, Xue-Jun
    Long, Jiang
    Xu, Jin
    Jiang, Guo-Liang
    RADIATION ONCOLOGY, 2015, 10
  • [23] The impact of second-line treatment after fist-line cisplatin plus gemcitabine in advanced biliary tract cancers: A mono-institutional retrospective study
    Gurreri, E.
    Chiaravalli, M.
    Bensi, M.
    Bagala, C.
    Di Stefano, B.
    Beccia, V.
    Spring, A.
    Monaca, F.
    Barone, D.
    Maratta, M.
    Tortora, G.
    Salvatore, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S302 - S302
  • [24] The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer
    Boeck, Stefan
    Heinemann, Volker
    FUTURE ONCOLOGY, 2008, 4 (01) : 41 - 50
  • [25] Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer
    Ekstrom, Anders
    Brun, Eva
    Eberhard, Jakob
    Segerlantz, Mikael
    ACTA ONCOLOGICA, 2021, 60 (12) : 1580 - 1588
  • [26] Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?
    Aprile, Giuseppe
    Negri, Francesca V.
    Giuliani, Francesco
    De Carlo, Elisa
    Melisi, Davide
    Simionato, Francesca
    Silvestris, Nicola
    Brunetti, Oronzo
    Leone, Francesco
    Marino, Donatella
    Santini, Daniele
    Dell'Aquila, Emanuela
    Zeppola, Tea
    Puzzoni, Marco
    Scartozzi, Mario
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 115 : 1 - 12
  • [27] Use of biological drugs in elderly cancer patients: A sustainable reality? A mono-institutional experience
    Fratino, L.
    Crivellari, D.
    Spina, M.
    Bearz, A.
    Simonelli, C.
    Beretta, M.
    Michieli, M. G.
    Dal Maso, L.
    Lazzarini, R.
    Tirelli, U.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S27 - S27
  • [28] Use of biological drugs in elderly cancer patients: A sustainable reality? A mono-institutional experience
    Fratino, L.
    Crivellari, D.
    Spina, M.
    Bearz, A.
    Simonelli, C.
    Berretta, M.
    Michieli, M. G.
    Dal Maso, L.
    Trovo, M. G.
    Tirelli, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] SECOND-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE SERIES
    Brungs, Daniel
    Aghmesheh, Morteza
    Sjoquist, Katrin
    Goldstein, David
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 168 - 168
  • [30] The role of total neoadjuvant therapy (TNT) in elderly patients with locally advanced rectal cancer: A mono-institutional retrospective study
    Lo Greco, M.
    Milazzotto, R.
    Liardo, R.
    La Rocca, M.
    Marano, G.
    Finocchiaro, I.
    Spatola, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S37 - S37
12345